USA:

Europe:

Email:

Consultation

Flow Cytometry

The Principle of Flow CytometryFlow cytometry (FCM) is a technology developed in the 1970s to quickly and accurately identify and classify immune cells and other cells. It mainly includes fluid flow technology, cell sorting and counting technology, as well as data collection and analysis technology, etc. At present, FCM has become an important biological tool for detecting various components of cells. It can not only quantitatively detect various cellular components in cell membranes, cytoplasm, nucleus, and various soluble biomolecular components in serum, but also study various functional states of cells. In recent decades, with the continuous discovery of new fluorescent substances and the increasing improvement of computer functions in data storage, display analysis, etc., FCM has transitioned from the previous qualitative description to quantitative research, and can conduct data statistics, which has greatly improved the scientific nature of experimental results. Based on the above characteristics, FCM has become an important research technique for clinical diagnosis and has a wide application prospect.

The Workflow of Flow Cytometry

The workflow of flow cytometry is as follows. Planning the workflow in advance as shown in the figure helps to improve the success rate of the experiment.

The Workflow of Flow Cytometry – Creative Biogene

Applications of Flow Cytometry

Flow cytometry is widely used in basic research and clinical practice, and plays an important role in the fields of cell biology, hematology, immunology, oncology, pharmacology, genetics, and clinical testing. It can assist in the diagnosis of various diseases such as blood diseases, cancer, autoimmune diseases, antiviral infections and so on. One of the most common applications is the diagnosis of blood-related cancers, such as leukemia and lymphoma. Take leukemia as an example, use fluorescent dye-treated specific monoclonal antibodies, such as CD2, CD7, CD10, CD14, CD19, CD33, CD34, CD41, CD64 and HLA-DR, etc., to detect the presence or absence of various cell components commonly seen in leukemia, thus achieving the purpose of diagnosis. In the early stage of malignant disease, there may be only a few cancer cells in the sample, and routine examination under the microscope may not be able to find these cancer cells, so flow cytometry is particularly useful in the early stage of malignant disease.

Advantages of Flow Cytometry

Flow cytometry is a new technology that can quickly, accurately, and high-throughput the characteristics or functions of a single particle to perform multi-parameter qualitative and quantitative analysis. The advantage of FCM is that it can quickly measure multiple indicators at the same time, and it transitions the diagnosis result from the previous qualitative description to the quantitative research, which greatly improves the scientific nature of the results.

Creative Biogene has accumulated years of experience in flow cytometry. We promise to provide you with the best diagnostic products. You can choose us with confidence.

Please contact us for more details.

Reference

  1. Peters J M., and Ansari M Q. (2011). "Multiparameter flow cytometry in the diagnosis and management of acute leukemia." Archives of pathology & laboratory medicine. 135.1: 44-54.
All Products
Cat# Product Name Product Type Inquiry
C-FC-4787A PE Anti-Human CD161 (HP-3G10) FCM Antibody Inquiry
C-FC-4788A PE Anti-Human CD163 (GHI/61) FCM Antibody Inquiry
C-FC-4789A PE Anti-Human CD19 (HIB19) FCM Antibody Inquiry
C-FC-4790A PE Anti-Human CD1a (HI149) FCM Antibody Inquiry
C-FC-4791A PE Anti-Human CD1c (L161) FCM Antibody Inquiry
C-FC-4792A PE Anti-Human CD20 (2H7) FCM Antibody Inquiry
C-FC-4793A PE Anti-Human CD206 (15-2) FCM Antibody Inquiry
C-FC-4794A PE Anti-Human CD235a (HIR2) FCM Antibody Inquiry
C-FC-4795A PE Anti-Human CD25 (BC96) FCM Antibody Inquiry
C-FC-4796A PE Anti-Human CD27 (O323) FCM Antibody Inquiry
C-FC-4797A PE Anti-Human CD279 (EH12.2H7) FCM Antibody Inquiry
C-FC-4798A PE Anti-Human CD279 (PD-1) (J110) FCM Antibody Inquiry
C-FC-4799A PE Anti-Human CD28 (CD28.2) FCM Antibody Inquiry
C-FC-4800A PE Anti-Human CD3 (Hit3a) FCM Antibody Inquiry
C-FC-4801A PE Anti-Human CD3 (OKT3) FCM Antibody Inquiry
C-FC-4802A PE Anti-Human CD3 (SK7) FCM Antibody Inquiry
C-FC-4803A PE Anti-Human CD3 (UCHT1) FCM Antibody Inquiry
C-FC-4804A PE Anti-Human CD314 (1D11) FCM Antibody Inquiry
C-FC-4805A PE Anti-Human CD34 (QBEnd-10) FCM Antibody Inquiry
C-FC-4806A PE Anti-Human CD38 (HB7) FCM Antibody Inquiry
For research use only. Not for any other purpose.
top